Screener
Solid Biosciences Inc. SLDB Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| —— | —— | —— | —— | —— | ||
| $44.27M+36.6% | $46.14M+49.3% | $38.14M+23.9% | $38.86M+42.2% | $32.42M+66.6% | ||
| $13.12M+41.4% | $11.17M+22.2% | $11.27M+23.5% | $9.2M+17.1% | $9.28M+11.4% | ||
| $57.38M+37.6% | $57.31M+43.1% | $49.4M+23.8% | $48.06M+36.6% | $41.69M+50.0% | ||
| -$57.38M-37.6% | -$57.31M-43.1% | -$49.4M-23.8% | -$48.06M-36.6% | -$41.69M-50.0% | ||
| —— | —— | $0-100% | -$336K-510% | $60K-31.8% | ||
| $2.59M+16.8% | $571K-25.8% | $0— | $2.28M-7.1% | $2.21M-18.5% | ||
| -$54.8M-38.8% | -$56.74M-44.4% | -$49.79M-16.9% | -$45.78M-39.9% | -$39.48M-57.5% | ||
| -$0.38+9.5% | -$0.52+11.9% | -$0.53+48.0% | -$0.48+39.2% | -$0.42+31.1% | ||
| -$56.99M-38.0% | -$56.91M-43.6% | -$48.94M-24.2% | -$47.68M-37.1% | -$41.31M-55.6% | ||
| -$57.38M-37.6% | -$57.31M-43.1% | -$49.4M-23.8% | -$48.06M-36.6% | -$41.69M-50.0% |
FAQ
- Is Solid Biosciences Inc. profitable?
- Solid Biosciences Inc. is not currently profitable: it reported a net loss of $207.1M over the trailing twelve months, a -1062.3% net margin.
- What is Solid Biosciences Inc.'s earnings per share?
- Solid Biosciences Inc.'s diluted EPS over the trailing twelve months is $-1.91.
- Where does Solid Biosciences Inc.'s income statement data come from?
- Every line is extracted from Solid Biosciences Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.